Health Care/Hospital

Reckitt and Shopee support Malaysians in fight against pandemic with 'Protection Starts Within' campaign

KUALA LUMPUR, Malaysia, June 17, 2021 /PRNewswire/ -- Reckitt, the global leader in health, hygiene and nutrition, partners with Shopee, the leading e-commerce platform inSoutheast Asia and Taiwan to launch its first "Protection Starts Within" regional initiative held across six markets. This ...

2021-06-17 09:00 3753

BitePRO Clothing Aims to Reduce Control and Restraint in Mental Health Care

WETHERBY, England, June 16, 2021 /PRNewswire/ -- According to protective clothing manufacturer,BitePRO , specifically designed protective clothing for health care professionals, as well as patients and service users, will help reduce the use of force within mental health...

2021-06-16 23:07 3979

Gannex Announces Positive Topline Results of the U.S. Phase I Trial of NASH Drug ASC42, an FXR Agonist

SHANGHAI, June 16, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of non-alcoholic steatohepatitis (NASH), today announces positive topline results of safety and pharmacodynamic ...

2021-06-16 21:00 4128

Proscia Lauded by Frost & Sullivan for Advancing the Standard of Cancer Research and Diagnosis with Its Concentriq(R) Platform

Proscia's differentiated approach to AI enablement and advanced features helps geographically distributed teams carry out their routine work from within a shared platform SANTA CLARA, Calif., June 16, 2021 /PRNewswire/ -- Based on its recent analysis of the North American digital pathology and i...

2021-06-16 20:15 2106

Frost & Sullivan Best Practices Recognizes Disruptive Companies with Prestigious Industry Awards

SINGAPORE, June 16, 2021 /PRNewswire/ -- Frost & Sullivan Best Practices Awards honor organizations that have accomplished innovative or disruptive breakthroughs and have continually demonstrated excellence. Frost & Sullivan follow...

2021-06-16 17:09 2711

Clarivate Report Demonstrates that Nations or Institutions with Diverse Research Priorities Respond More Comprehensively to Unprecedented Scientific Challenges

Forward-looking approach offers a valuable new tool for anticipating and preparing for the unexpected LONDON, June 16, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new Global ...

2021-06-16 15:00 9581

Carepool Asia - Malaysia's first multi-disciplinary digital healthcare platform that offers unlimited telehealth appointments

KUALA LUMPUR, Malaysia, June 16, 2021 /PRNewswire/ -- CAREPOOL ASIA, an innovative digital health platform launches its new, affordable digital health packages, the first telehealth platform that offers unlimited consultation services via a monthly subscription fee, as low asRM170 per month for t...

2021-06-16 12:35 3252

Medidata Becomes First Company to Offer End-to-End, Unified, Secure Platform for Decentralization of Clinical Trials (DCT)

* The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end decentralization for sponsors and CROs * The unique Medidata Trial Dial™ concept provides the industry's highest level of customization for c...

2021-06-16 09:11 3529

DoctorOnCall, Pfizer and UOB Malaysia form Malaysia's first tripartite collaboration to improve children's access to pneumococcal vaccine

KUALA LUMPUR, Malaysia, June 16, 2021 /PRNewswire/ -- DoctorOnCall, Pfizer and UOB Malaysia today jointly launched"ASK4VACCINE", a financing programme that aims to improve children's access to pneumococcal vaccine inMalaysia. The " ASK4VACCINE" programme enables Malaysian parents to give their chi...

2021-06-16 09:00 3707

Galimedix Accelerating Development of Its Next-Generation Oral Anti-Amyloid Beta Drug GAL-201 for Alzheimer's Disease

Following recent FDA approval of Biogen's Alzheimer antibody drug ADUHELM (TM), targeting oligomers of amyloid beta, Galimedix aims for first patients with its GAL-201 oral small molecule drug within one year. KENSINGTON, Md., June 16, 2021 /PRNewswire/ -- Galimedix, Inc., a clinical-stage bioph...

2021-06-16 04:38 1337

Qynapse to present clinical results of QyScore® for Alzheimer's Disease and Multiple Sclerosis at the 7th Congress of the European Academy of Neurology

BOSTON, June 15, 2021 /PRNewswire/ -- QYNAPSE Inc., a medical technology company commercializing the most advanced artificial intelligence neuroimaging platform, today announced it will present clinical data on QyScore® for Alzheimer's disease and multiple sclerosis at the 7th Congress of the Eur...

2021-06-15 18:00 3122

Hummingbird Bioscience to Speak at 2021 Virtual Symposium: "VISTA: A New Immune Checkpoint in Cancer, Autoimmunity and Beyond"

HOUSTON and SINGAPORE, June 14, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced that its Chief Scientific Officer and co-founder, DrJerome Boyd-Kirkup, will be speakin...

2021-06-15 13:04 1726

Innovent Announces First Overweight or Obese Subject Dosed in A Phase 2 Clinical Trial of IBI362 (a GLP-1 and Glucagon Receptor Dual Agonist) in China

SAN FRANCISCO and SUZHOU, China, June 15, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2021-06-15 12:00 5341

TCEB: Hybrid Lions Clubs International Convention In Nakhon Ratchasima A Success Against COVID-19 Situation

BANGKOK, June 14, 2021 /PRNewswire/ -- TCEB-supported Lions Clubs International Thailand Convention proved a success, attracting over 2,000 attendees nationwide to a hybrid format event the association held for the first time under strict hygiene standards and enhanced sustainability consideratio...

2021-06-15 10:10 3078

iAPPS Health Group, a Fin-MedTech company, announces former Senior Minister of State for Health Dr. Lam Pin Min as its Chairman

SINGAPORE, June 15, 2021 /PRNewswire/ -- iAPPS Health Group ("iHG") announced the appointment of former Senior Minister of State for Health, Dr. Lam Pin Min, as Chairman of its board of directors. Dr. Lam Pin Min brings with him a wealth of relevant experience as a veteran in the healthcare...

2021-06-15 09:35 3525

The U.S. FDA Approved IND Application to Investigate Combination of Asieris' APL-1202 and BeiGene's Tislelizumab as Neoadjuvant Therapy for MIBC Patients

SHANGHAI, June 15, 2021 /PRNewswire/ -- Asieris Pharmaceuticals (Asieris) today announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application of oral APL-1202 in combination with BeiGene's tislelizumab as neoadjuvant therapy in patients wit...

2021-06-15 09:06 2458

BookDoc Seeks Strategic Partnerships for Expansion Plan

KUALA LUMPUR, Malaysia, June 15, 2021 /PRNewswire/ -- With the COVID-19 pandemic mandating social distancing as the new norm, there has been a clear shift in the methods through which people seek healthcare services. While previously, physical consultations have always been considered superior, m...

2021-06-15 08:34 4041

Ascentage Pharma Announces IND Clearance by the US FDA for Lisaftoclax (APG-2575) as Single Agent or in Combinations for the Treatment of ER+ Breast Cancer and Other Solid Tumors

SUZHOU, China, and ROCKVILLE, Md., June 15, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Investigational Ne...

2021-06-15 07:39 18268

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial

* 93% efficacy against predominantly circulating Variants of Concern and Variants of Interest * 91% efficacy in high-risk populations * 100% efficacy against variants "not considered Variants of Concern/Interest" * All COVID-19 hospitalizations/death occurred in the placebo group * Company...

2021-06-15 07:06 6417

BioVaxys Receives Positive FDA Response For Pre-IND Review For CoviDTH Clinical Development

VANCOUVER, British Columbia, June 15, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF)("BioVaxys"), is pleased to announce today that the US Food and Drug Administration (FDA) has reviewed its Pre-IND request for a Type B review of its CoviDTH program and has d...

2021-06-15 04:19 16209